COVID-19 Resources

HAP is actively monitoring developments and continues to engage with Pennsylvania Department of Health and the Centers for Disease Control and Prevention to provide members with the most current information and resources.


Multisystem Inflammatory Syndrome Associated with COVID-19 Case Report Form, May 28, 2021

COVID-19 Treatments

Information Sheet - Paxlovid Eligibility and EffectivenessAugust 2022

Casirivimab and Imdevimab—Administration together for mild to moderate coronavirus disease in adults and pediatric patients 12 years of age and older and weighing at least 40 kg with positive viral testing results, and who are at high risk for progressing to severe COVID-19.

Baricitinib (Olumiant) in combination with remdesivir (Veklury)—Emergency use for suspected or laboratory-confirmed COVID-19 in hospitalized adults and pediatric patients 2 years of age or older requiring oxygen, invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO)

Bamlanivimab—Treatment of mild to moderate COVID-19 in adult and pediatric patients with positive SARS-CoV-2 viral testing results and age 12 years and older and weighing at least 40 kilograms

COVID-19 convalescent plasma—Treatment of hospitalized patients with COVID-19

Regiocit replacement solution—Replacement solution only in adult patients treated with continuous renal replacement therapy (CRRT)

Fresenius Kabi Propoven 2%—Maintaining sedation via continuous infusion in patients older than 16 years with suspected or confirmed COVID-10 who require mechanical ventilation in an ICU

Remdesivir for certain hospitalized COVID-19 Patients—Emergency use for treatment of suspected or laboratory confirmed COVID-19 in hospitalized pediatric patients weighing 3.5 kg to less than 40 kg or hospitalized pediatric patients less than 12 years of age weighing at least 3.5 kg

Vaccine Information



Pfizer-Biontech COVID-19 Vaccine

Supplies & PPE

HAP Resources

Federal Resources

Regulatory Policy

The Centers for Medicare & Medicaid Services:

Online Resources

HAP News

April 09, 2024

COVID-19’s Financial Impact on Rural Hospitals

COVID-19 provider relief funds were critical to support rural hospitals during the pandemic, but financial pressures on these facilities continued to persist after the federal funding expired.